FDA rejects Disc's rare disease drug despite commissioner's voucher Read more
'It's really a dire time for patients': Biohaven CEO says FDA red tape is blocking access to rare disease treatments Read more
After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio Read more
February 4, 2025 @ 5:30 pm

An agenda-free networking evening which provides opportunities for key people from companies working in or with the life sciences sector to network and socialise with their peers in an informal setting over a drink or two.